Epigral Ltd Financials
Company Logo

Epigral Ltd Financial Statement

Epigral Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue631.03
Operating Expense454.25
Net Profit86.62
Net Profit Margin13.73
Earning Per Share20.08
EBIDTA147.38
Effective Tax Rate8.51

Epigral Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual2,550.13
Operating Expenses Annual1,839.41
Operating Profit Annual725.93
Interest Annual53.27
Depreciation132.56
Net Profit Annual356.70
Tax Annual183.40

Epigral Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning3.18
Cash Flow from Operations440.56
Cash Flow from Investing-261.56
Cash Flow from Financing-163.54
Cash Flow at the End18.64

Epigral Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)28.47
PBIT Margin (%)23.27
PBT Margin (%)22.83
Net PROFIT Margin (%)13.99
Return On Networth / Equity (%)22.59
Return On Networth /Employed (%)25.10
Return On Assets (%)15.11
Total Debt / Equity (X)0.47
Asset Turnover Ratio (%)1.08

Epigral Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual2,238.02
Total Current Assets Annual775.24
Non Current Assets Annual2,376.20
Total Shareholders Funds Annual1,903.53
Total Assets Annual3,151.44

Epigral Ltd Earning Calls

EPS (INR)

Expected

20.14

Reported

20.14

Surprise

0.00%

Dec 2024

EPS beaten by 0.00%

Sep 2024

EPS beaten by 0.96%

Jun 2024

EPS beaten by 0.00%

FAQS on Epigral Ltd Financials

As of Jun 21, 2025, Epigral Ltd has a market capitalization of 8,191.68 Cr. Value Research classifies it as a Mid-Cap company.

Yes, Epigral Ltd is with a debt-to-equity ratio of 0.31.

In FY 2024 , Epigral Ltd recorded a total revenue of approximately 2,550.13 Cr marking a significant milestone in the company's financial performance.

Epigral Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.4% and 0.1% annually, respectively..

Epigral Ltd's current PE ratio is 22.97.

Epigral Ltd's ROCE averaged 23.4% from the FY ending March 2023 to 2025, with a median of 23.7%. It peaked at 30.2% in March 2023, reflecting strong capital efficiency over the period..

Epigral Ltd's latest EBIT is Rs. 593.37 Cr, surpassing the average EBIT of Rs. 515.19 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions